"Split-gene" reconstituted transketolase (gene ChTK-F) from Carboxydothermus hydrogenoformans
Enzyme Description
Extremophile
Yes
"hyperthermophilic" organism
EC Number
Sequence
MQDEILNLKLIANQLRQHVVKMVGEANSGHPGGSLSAADILAVLFFKEMRIDPANPKWQDRDRFVLSKGHASPVLYAALAERGFFPKEWLSQFRKINSPLQGHPDMKKVPGVEMSTGSLGQGFSTAVGMALGLKLDRSPARVYVLLGDGEIQEGIVWEAAMAAAHYKLNNLTAILDYNGLQIDGPVQEVMNPEPVADKWRSFGFKVITVDGHNIPEIINAIDAARLHLEGPTIIIAKTVKGKGVSFMENRVEWHGSAPKPEQVAEALSELQVGREKLWEEMGGIATREAYGKALVELGQENPKIVVLDADLSKSTKTSDFAKAFPERFFNMGIAEQNLMGVAAGLSTVGKIPFASTFAVFAAGRAFEIIRNSICYPKLNVKIAATHAGLTVGEDGASHQAIEDLALMRVLPNMQVFVPADAAQTRAIVKKAAEIEGPVYIRLGRSGVPEVFSPDIRFEPGRGTVLKEGKDVTIVALGIMTAKALEAAKMLEAEGIAARVVDMASLKPIDRELLVESARLTGAVVTAEEHSVIGGLGSAVAEVLSEEYPIPVVKVGVNDVFGESGTPQALLEKYGLTARDVVAAVQKALTLKR
Paul James et al. (2020)
β A 'Split-Gene' Transketolase From the Hyper-Thermophilic Bacterium Carboxydothermus hydrogenoformans: Structure and Biochemical Characterization
Frontiers in Microbiology
Β· doi:10.3389/fmicb.2020.592353 β
Β· Stability - Incubation
▼
Database ID
β
Sequence Annotation
Explicit - Provided
Protein Source
Recombinant, host bacterium Escherichia coli BL21 (DE3)
Experimental Data (18 measurements)
18 measurements
| Property | Assay | Solvent | Solvent Volume | Aqueous Reference | Measured Value | Units | Solution | pH | Temperature | Substrate(s) | Product(s) | Cofactor(s) | Shaking | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Dimethyl Sulfoxide (DMSO) | 10% | 100.0 | 47.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetonitrile | 50% | 100.0 | 49.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetonitrile | 25% | 100.0 | 51.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetonitrile | 10% | 100.0 | 52.1 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetone | 50% | 100.0 | 52.1 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetone | 25% | 100.0 | 49.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Acetone | 10% | 100.0 | 52.1 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Dimethyl Sulfoxide (DMSO) | 50% | 100.0 | 51.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Dimethyl Sulfoxide (DMSO) | 25% | 100.0 | 49.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Methanol | 10% | 100.0 | 105.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Isopropanol | 50% | 100.0 | 60.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Isopropanol | 25% | 100.0 | 58.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Isopropanol | 10% | 100.0 | 60.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Ethanol | 50% | 100.0 | 44.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Ethanol | 25% | 100.0 | 42.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Ethanol | 10% | 100.0 | 70.1 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Methanol | 50% | 100.0 | 40.0 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
| Stability - Incubation | Activity after incubation (1 hour at room temperature), measured by HPLC (erythrulose production and Hydroxypyruvic acid consumption) in aqueous phase | Methanol | 25% | 100.0 | 54.9 | % | Incubation: 25 mM Tris-HCl buffer, 100 mM NaCl, Assay: 10 mM HEPES buffer, 100 mM NaCl, 9 mM CaCl2 | Incubation: 7.5, Assay: 7.2 | Incubation: Room temperature, Assay: Room temperature | ? mM Glycoaldehyde, ? mM Hydroxypyruvic acid | Carbon Dioxide (CO2) , Erythrulose | Assay: 2 mM thiamine pyrophosphate | β | Non-incubated control (in %), assay in aqueous phase | Diluted organic solvent in asssay ("no greated than 7,5%") |
Visualization : Stability β Incubation
One bar per measurement. Colour = solvent, shade = solvent volume.